CytomX Therapeutics, Inc. 4
4 · CytomX Therapeutics, Inc. · Filed Jun 22, 2017
Insider Transaction Report
Form 4
GLUCK FREDERICK W
Director
Transactions
- Award
Stock Option (right to buy)
2017-06-20+14,000→ 14,000 totalExercise: $13.78Exp: 2027-06-19→ Common Stock (14,000 underlying)
Footnotes (1)
- [F1]The option vests in full on June 20, 2018 subject to the Reporting Person's continued service to the Issuer through such date.